124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors.

NCT01931488 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER_GOV

Sponsor class

Conditions

Parkinson Disease
Neuroendocrine Tumors

Interventions

OTHER: MIBG label with I123 or I124
DEVICE: SPECT imaging

Sponsor

Tel-Aviv Sourasky Medical Center